Form 4 for QURE uniQure N.V.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-13 · accession 0000904454-23-000402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-20 | 2023-06-13 | QURE | Soteropoulos Paula | Dir | A - Grant | $0.00 | +8,700 | 24.7K | +54% | $0 |
| D | 2023-06-20 | 2023-06-16 | QURE | Soteropoulos Paula | Dir | S - Sale | $18.99 | -2,275 | 22.4K | -9% | -$43.2K |
| D | 2023-06-20 | 2023-06-13 | QURE | Soteropoulos Paula | Dir | A - Grant | $0.00 | +17.1K | 17.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-06-13 | A | A | 8,700 | $0.00 | 24,698 | D | — | — | (F1) Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. |
| 2 | Common | Ordinary Shares | 2023-06-16 | S | D | 2,275 | $18.99 | 22,423 | D | — | — | (F3) As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units. (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.95 to $19.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-06-13 | A | A | 17,060 | $0.00 | 17,060 | D | $20.18 · — to 2033-06-13 | 17,060 Ordinary Shares | (F2) The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. |